ASTRAZENECA SAYS FARXIGA REDUCED DEATH FROM ANY CAUSE BY 31% IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) IN DAPA-CKD TRIAL
Stock Market News in real time
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
12,050 GBX | -0.87% | +0.52% | 234B | ||
2,962 JPY | -0.17% | +0.82% | 1.29B | ||
- Stock Market
- Stock Market News in real time
- Economy
- Astrazeneca Says Farxiga Reduced Death From Any Cause By 31% In Patients With Chronic Kidney Disease (Ckd) In Dapa-Ckd Trial